Yes, not good at all.The announcement was also poorly written....

Yes, not good at all.

The announcement was also poorly written. They put forward timetable issues with PI88, but they also stop working on their product like the melanoma - so you wonder if the delays on PI88 were the real reason.

Also, they were using external agencies - and I would have thought that the main reason to use them was to "guarantee" a certain roll-out timetable. And these agencies should be aware of the various issues they face when dealing with countries like China and Vietnam. You don't need to be a genius to expect more regulatory challenges than in other countries.

Weak management team, poor strategic planning work.

Not good at all, this one will hurt.